Edwards Lifesciences (EW)

SG&A Expense Growth

7.47%

Quarterly · Period ending:

EW logo

EW SG&A Expense Growth

Latest reported7.47%
EW Quarterly SG&A Growth (QoQ) (0.00% → 7.47%)
High-resolution chart · PNG

EW sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Edwards Lifesciences SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
7.4684%
-13.3853%
17.159%
2.51%
7.7947%
-5.3263%
16.7299%
-6.5217%
5.2288%
2.8325%
9.0861%
-6.9444%
-5.9363%
6.1557%
8.9319%
-7.7506%
10.451%
-12.6651%
16.4515%
-2.6731%
13.0553%
-2.3029%
10.1463%
11.4938%
-10.6286%
-11.2453%
13.3312%
-0.712%
10.1212%
-2.6708%
7.1349%
-1.7525%
7.4539%
-3.9563%
8.6814%
0.2052%
6.3728%
-1.9264%
1.7865%
0.3059%
7.5693%
-4.3185%
4.8585%
-0.8883%
5.6296%
-9.2335%
0.405%
3.109%
9.2799%
3.5171%
5.5402%
-4.699%
2.2678%
4.1034%
6.0191%
-8.0044%
2.9345%
8.4455%
-1.2689%
1.4093%
8.5828%
5.5478%
7.0677%
-5.4054%
4.9254%
1.285%
4.9167%
-1.8677%
5.4143%
1.4143%
0.7544%
-5.6917%
10.3839%
0.0873%
10.9496%
1.4749%
3.144%
3.6803%
3.7077%
-5.4639%
5.4348%
5.6257%
1.397%
-4.6615%
5.257%
3.5067%
3.7641%
-1.6049%
5.8824%
5.9557%
2.4113%
-6.9921%
6.1625%
3.9301%
26.7528%
-0.1842%
7.1006%
1.1976%
7.9741%
-11.9545%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.